Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Price to free cash flow
As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a price to free cash flow of 14.1×. Over the past ten years it has ranged from 0.0× (December 2025) to 261× (November 2015); the current reading is higher than 57% of that period. That is below the Medical Devices industry median of 28.8× and below the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 44.2× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 8.9× | (24.55%) |
| FY2020 | 11.7× | (15.29%) |
| FY2019 | 13.9× | 18.73% |
| FY2018 | 11.7× | (45.06%) |
| FY2017 | 21.3× | (1.53%) |
| FY2016 | 21.6× | (66.58%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 11.3× | (19.68%) |
| Jun 2026 | 14.0× | (4.99%) |
| Mar 2026 | 14.8× | (66.58%) |
| Dec 2025 | 44.2× | — |
| 37 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 7.1× |
| PHG Koninklijke Philips N.V. | 14.1× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 18.2× |
| BSX Boston Scientific Corporation compare | 19.3× |
| GEHC GE HealthCare Technologies Inc. compare | 19.9× |
| STE STERIS plc compare | 26.4× |
| DXCM DexCom, Inc. compare | 28.8× |
| EW Edwards Lifesciences Corporation compare | 41.5× |
| GKOS Glaukos Corporation compare | 360× |
| Medical Devices industry median | 28.8× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement